Clinical Trials on Essential Thrombocythemia in Ireland
Total 33 results
-
Queen's University, BelfastMayo Clinic; University Hospital Southampton NHS Foundation Trust; University... and other collaboratorsCompletedPrimary Myelofibrosis | Polycythemia Vera | Essential ThrombocythemiaUnited Kingdom
-
Novartis PharmaceuticalsCompletedIdiopathic Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia-Vera MyelofibrosisUnited Kingdom, Ireland, Germany, Italy, France
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy, United Kingdom, France
-
Copenhagen University Hospital at HerlevUnknownPolycythemia Vera | Essential ThrombocythemiaSweden, United Kingdom, Denmark, Netherlands
-
Novartis PharmaceuticalsCompletedMyelofibrosisBelgium, Colombia, Canada, Italy, Spain, Austria, Germany, Czechia, Thailand, Hungary, Greece, Argentina, Brazil, Israel, Russian Federation, Mexico, Portugal, South Africa, Tunisia, Slovakia, Saudi Arabia, Poland, Algeria, Ireland, Mor...
-
CTI BioPharmaTerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada, France, United Kingdom, Australia, Belgium, Germany, New Zealand, Netherlands, Russian Federation, Hungary, Czechia
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, France, Germany, Spain, Israel, Bulgaria, Romania, Japan, Taiwan, Korea, Republic of, Australia, Belgium, Canada, Netherlands, Singapore, Poland, Hungary, Denmark, Sweden, United Kingdom, Czechia, Austria
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Puerto Rico
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia VeraAustralia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom
-
Novartis PharmaceuticalsCompletedBone Marrow Diseases | Hematologic Diseases | Blood Coagulation Disorders | Hemorrhagic Disorders | Primary Myelofibrosis | Myeloproliferative Disorders | Polycythemia Vera | Thrombocytosis | Essential Thrombocythemia | Blood Platelet DisordersUnited Kingdom, Belgium, Canada, France, Australia, Netherlands, Spain, Denmark, Ireland, Italy, Germany
-
ShireCompletedThrombocythemia, EssentialSpain, United Kingdom, Greece, Denmark, Italy, France, Finland, Norway, Sweden, Germany, Cyprus, Ireland, Netherlands, Portugal
-
NovartisCompletedHypertensionSlovakia, Italy, Netherlands, Argentina, Germany, Poland, Czech Republic, Iceland
-
RostaQuo S.p.A.UnknownEssential HypertensionIreland, Italy, Poland
-
Praxis Precision MedicinesWithdrawn
-
Cala Health, Inc.Completed
-
TakedaCompleted
-
Cala Health, Inc.CompletedEssential TremorUnited States
-
TakedaCompletedEssential HypertensionUnited States, Canada
-
TakedaCompletedEssential HypertensionUnited States, Russian Federation
-
Symplmed Pharmaceuticals LLCCompletedEssential HypertensionUnited States
-
TakedaCompleted
-
Jazz PharmaceuticalsActive, not recruitingEssential TremorUnited States, Spain, Poland, Germany
-
Idorsia Pharmaceuticals Ltd.CompletedEssential HypertensionUnited States, Canada, Israel, Puerto Rico
-
TakedaCompletedEssential HypertensionUnited States, Chile, Mexico
-
GlaxoSmithKlineCompleted
-
Eli Lilly and CompanyCompletedPrimary HypertensionUnited States, Puerto Rico, Canada
-
TheracosCompletedEssential HypertensionUnited States
-
TakedaCompletedHypertensionUnited States, Mexico, Chile, Peru
-
BiogenCompleted
-
PfizerCompletedHypertension | Blood Pressure, HighUnited States
-
Sage TherapeuticsBiogenActive, not recruiting
-
Praxis Precision MedicinesCompletedEssential TremorUnited States, Canada
-
NicOxCompletedHypertension | OsteoarthritisUnited States